Bonneville, France

Alexandra Jouhanneaud

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 1.9

ph-index = 3

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2012-2020

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Innovations by Alexandra Jouhanneaud

Introduction

Alexandra Jouhanneaud is a prominent inventor based in Bonneville, France. She has made significant contributions to the field of cancer treatment, holding a total of 12 patents. Her work focuses on innovative methods and compositions for treating cancers that express the IGF-1R receptor.

Latest Patents

Among her latest patents is a composition for the treatment of IGF-1R expressing cancer. This invention relates to a method for treating such cancers, as well as to compositions and kits designed for this treatment. One aspect of this invention involves the combined use of a first antibody to determine the IGF-1R status of a cancer and a second antibody used as an antibody-drug conjugate (ADC) for the treatment of the cancer. Another notable patent is related to IGF-1R antibodies characterized by specific CDR sequences, which are intended for use in detection methods of IGF-1R expressing tumoral cells.

Career Highlights

Throughout her career, Jouhanneaud has worked with notable companies, including Pierre Fabre Medicament. Her innovative approaches have positioned her as a key figure in the development of cancer therapies.

Collaborations

She has collaborated with esteemed colleagues such as Liliane Goetsch and Christine Klinguer-Hamour, contributing to the advancement of her research and inventions.

Conclusion

Alexandra Jouhanneaud's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. Her patents and collaborations highlight her dedication to improving patient outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…